Table 1 Methodological summary of the studies.
Study + year | n | Outcome | Intervention | Duration | Modality | Analysis | Validation |
|---|---|---|---|---|---|---|---|
Costafreda et al. 2009—1 | 16 | Remission | CBT | 16 wk | tbfMRI | SVM | LOO CV |
Siegle et al. 2012 | 12 | Response | CBT | 12 wk | tbfMRI | RF | Ind. replication |
Queirazza et al. 2019 | 37 | Response | CBT | 6–10 wk | tbfMRI | SVM, LR | LOO nested CV |
Van Waarde et al. 2015 | 45 | Remission | ECT | 10 wk | rsfMRI | lSVM | LOO CV |
Moreno-Ortega et al. 2019 | 19 | Remission | ECT | ns | rsfMRI | LR | LOO CV |
Sun et al. 2019 | 122 | Remission + remission | ECT | 3–4 wk | rsfMRI | LR | LOO CV |
Redlich et al. 2016 | 23 | Response | ECT | 3–8 wk | sMRI | lSVM/GPC | LOO CV |
Wade et al. 2016 | 34 | Response | ECT | 2–7 wk | sMRI | RBFSVM | LOO CV |
Cao et al. 2018 | 24 | Response + remission | ECT | 3–4 wk | sMRI | lSVM | LOO CV |
Jiang et al. 2018 | 38 | Remission | ECT | 3–4 wk | sMRI | LR | 10-fold LOO CV+ Independent cohort rep |
Wade et al. 2017 Leaver et al. 2017 | 44a | Remission Response | ECT ECT | ns ns | sMRI rsfMRI, aslMRI | RF RBFSVM | Nested CV 5-fold LOO CV |
Drysdale et al. 2017 | 124 30 | Response | rTMS | 4–6 wk | rsfMRI | lSVM | LOO CV Ind. replication |
Cash et al. 2019 | 33 | Remission | rTMS | 5–8 wk | rsfMRI | lSVM | LOO + k fold CV |
Costafreda et al. 2009—2 Nouretdinov et al. 2011 | 18a | Remission Remission | SSRI SSRI | 8 wk 8 wk | sMRI sMRI | lSVM TCP | LOO CV LOO CV |
Gong et al. 2011 | 46 | Response | SSRI/TCA/SNRI | 12 wk | sMRI | lSVM | LOO CV |
Marquand et al. 2008 | 20 | Response | SSRI | 8 wk | tbfMRI | lSVM | LOO CV |
Godlewska et al. 2018 | 32 | Response | SSRI | 6 wk | tbfMRI | LR | LOO CV |
Meyer et al. 2019 | 22 | Remission/non-response | SSRI | 8 wk | tbfMRI | LR | LOO CV |
Karim et al. 2018 | 49 | Remission | SNRI | 12 wk | tbfMRI | LR | 10-fold LOO CV |
Patel et al. 2015 | 19 | Remission | SSRI/SNRI | ns | rsfMRI, DTI, sMRI | ADTree/lSVM/RBFSVM/L1LR | Nested LOO CV |
iSPOT trials | 77a | SSRI/SNRI | 8 wk | ||||
Korgaonkar et al. 2014 | Remission | DTI | LR | K-fold CV | |||
Williams et al. 2015 | Response | tbfMRI | LDA | LOO CV | |||
Goldstein-Piekarski et al. 2016 | Remission | tbfMRI | LR | 10-fold LOO CV | |||
Grieve et al. 2016 | Non-remission | DTI | LR | Independent rep | |||
Goldstein-Piekarski et al. 2018 | Remission | rsfMRI | LR | LOO CV |